KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Current Assets (2016 - 2025)

Evolent Health has reported Current Assets over the past 11 years, most recently at $506.4 million for Q4 2025.

  • Quarterly results put Current Assets at $506.4 million for Q4 2025, down 16.59% from a year ago — trailing twelve months through Dec 2025 was $506.4 million (down 16.59% YoY), and the annual figure for FY2025 was $506.4 million, down 16.59%.
  • Current Assets for Q4 2025 was $506.4 million at Evolent Health, down from $570.1 million in the prior quarter.
  • Over the last five years, Current Assets for EVH hit a ceiling of $727.9 million in Q1 2025 and a floor of $393.8 million in Q3 2022.
  • Median Current Assets over the past 5 years was $522.5 million (2021), compared with a mean of $542.9 million.
  • Biggest five-year swings in Current Assets: surged 96.66% in 2021 and later fell 17.65% in 2022.
  • Evolent Health's Current Assets stood at $524.0 million in 2021, then decreased by 8.76% to $478.1 million in 2022, then soared by 43.01% to $683.7 million in 2023, then decreased by 11.2% to $607.1 million in 2024, then fell by 16.59% to $506.4 million in 2025.
  • The last three reported values for Current Assets were $506.4 million (Q4 2025), $570.1 million (Q3 2025), and $562.3 million (Q2 2025) per Business Quant data.